Collegium Pharmaceutical (COLL) Financials: Revenue & Earnings
$754.30M
Market Cap
—
P/E
—
Forward P/E
—
Score
COLL price $23.17 +0.17 +0.74%
COLL fair value $139.96. Price $23.17. Price is 83% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 92% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 328.28M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 32.56M. Net debt 689.46M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | 1.86 | — | 216.03M |
| 2026-08-06 | 1.92 | 1.72 | 199.88M | 199.62M |
| 2026-05-07 | 1.76 | 1.52 | 193.52M | 184.47M |
| 2026-02-26 | 2.04 | 2.14 | 205.45M | 206.36M |
| 2025-11-06 | 2.25 | 1.86 | 209.36M | 206.16M |
| 2025-08-07 | 1.68 | 1.62 | 188.00M | 191.31M |
| 2025-05-08 | 1.49 | 1.43 | 177.76M | 173.08M |
| 2025-02-27 | 1.77 | 1.54 | 181.95M | 179.68M |
| 2024-11-07 | 1.61 | 1.59 | 159.30M | 179.48M |
| 2024-08-08 | 1.62 | 1.49 | 145.28M | 143.94M |
| 2024-05-09 | 1.45 | 1.47 | 144.92M | 146.94M |
| 2024-02-22 | 1.58 | 1.38 | 149.75M | 147.98M |
| 2023-11-07 | 1.34 | 1.22 | 136.71M | 138.53M |
| 2023-08-03 | 1.26 | 1.22 | 135.55M | 138.40M |
| 2023-05-04 | 1.32 | 1.33 | 144.77M | 138.47M |
| 2023-02-23 | 1.09 | 1.09 | 129.62M | 125.22M |
| 2022-11-03 | 1.10 | 1.38 | 127.01M | 124.38M |
| 2022-08-04 | 0.13 | 1.44 | 123.55M | 121.13M |
| 2022-05-10 | 0.44 | 0.90 | 83.75M | 78.67M |
| 2022-02-24 | -0.73 | 1.04 | 27.36M | 81.53M |
| 2021-11-04 | 0.22 | 0.95 | 78.84M | 85.13M |
| 2021-08-05 | 0.27 | 0.34 | 82.94M | 84.77M |
| 2021-05-06 | 0.41 | 0.42 | 87.72M | 83.33M |
| 2021-02-25 | 0.20 | 0.39 | 76.27M | 99.94M |
| 2020-11-05 | 0.32 | 0.41 | 79.18M | 54.43K |
| 2020-08-05 | 0.23 | 0.31 | 78.06M | 67.88M |
| 2020-05-07 | 0.01 | 0.41 | 76.51M | 2.83B |
| 2020-02-27 | -0.07 | -0.09 | 74.20M | 106.00M |
| 2019-11-06 | -0.18 | -0.12 | 72.94M | 60.78M |
| 2019-08-07 | 0.10 | -0.19 | 75.04M | 101.84M |
| 2019-05-08 | -0.05 | -0.30 | 74.52M | 61.67M |
| 2019-02-27 | -0.10 | -0.12 | 73.43M | 95.18M |
| 2018-11-08 | -0.25 | -0.11 | 70.18M | 47.72M |
| 2018-08-08 | -0.15 | -0.44 | 73.06M | 76.71M |
| 2018-05-09 | -0.57 | -0.49 | 63.75M | 54.80M |
| 2018-03-07 | -0.54 | -0.57 | 10.79M | 11.39M |
| 2017-11-08 | -0.45 | -0.74 | 11.95M | 19.65M |
| 2017-08-09 | -0.72 | -0.81 | 3.56M | 4.00M |
| 2017-05-10 | -0.79 | -0.98 | 2.17M | 2.69M |
| 2017-03-09 | -1.02 | -1.07 | 1.30M | 1.37M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-08 | SANTINI GINO | Buy | 8.70K | $16.49 | 143.46K |
| 2026-06-08 | SANTINI GINO | Sell | 8.70K | $16.49 | 143.46K |
| 2026-05-18 | Freund John Gordon | Sell | 20 | $34.05 | 681 |
| 2026-05-15 | Freund John Gordon | Buy | 8.70K | $16.49 | 143.46K |
| 2026-05-15 | Freund John Gordon | Sell | 4.13K | $34.54 | 142.55K |
| 2026-05-15 | Freund John Gordon | Sell | 8.70K | $16.49 | 143.46K |
| 2026-05-14 | Lurker Nancy | Buy | 8.74K | — | — |
| 2026-05-14 | Paya Carlos V | Buy | 8.74K | — | — |
| 2026-05-14 | Freund John Gordon | Buy | 8.74K | — | — |
| 2026-05-14 | BOHLIN GAREN G | Buy | 8.74K | — | — |
| 2026-05-14 | Glancy Donovan Michael | Buy | 17.48K | — | — |
| 2026-05-14 | Balice-Gordon Rita J. | Buy | 8.74K | — | — |
| 2026-05-14 | SANTINI GINO | Buy | 8.74K | — | — |
| 2026-05-14 | Glancy Donovan Michael | Other | 0 | — | — |
| 2026-05-13 | Lurker Nancy | Sell | 4.50K | $35.97 | 161.86K |
| 2026-05-11 | BOHLIN GAREN G | Buy | 8.70K | $16.49 | 143.46K |
| 2026-05-11 | BOHLIN GAREN G | Sell | 8.70K | $37.18 | 323.49K |
| 2026-05-11 | BOHLIN GAREN G | Sell | 8.70K | $16.49 | 143.46K |
| 2026-03-18 | Dieter David | Sell | 13.98K | $34.92 | 488.10K |
| 2026-03-17 | Dieter David | Sell | 8.84K | $35.72 | 315.76K |
| 2026-03-09 | Dieter David | Sell | 6.22K | $36.65 | 228.11K |
| 2026-03-03 | Dreyer Scott | Sell | 46.42K | $40.36 | 1.87M |
| 2026-03-03 | Dreyer Scott | Sell | 3.56K | $40.99 | 145.88K |
| 2026-02-10 | Dieter David | Buy | 9.01K | — | — |
| 2026-02-10 | Dieter David | Sell | 2.78K | $46.75 | 130.01K |
| 2026-02-10 | Dieter David | Buy | 22.19K | — | — |
| 2026-02-10 | Karnani Vikram | Buy | 32.53K | — | — |
| 2026-02-10 | Karnani Vikram | Sell | 11.30K | $46.75 | 528.09K |
| 2026-02-10 | Karnani Vikram | Buy | 79.26K | — | — |
| 2026-02-10 | Smith Thomas B | Buy | 22.77K | — | — |
| 2026-02-10 | Smith Thomas B | Sell | 5.90K | $46.75 | 275.68K |
| 2026-02-10 | Smith Thomas B | Sell | 11.54K | $46.75 | 539.40K |
| 2026-02-10 | Smith Thomas B | Buy | 14.27K | — | — |
| 2026-02-10 | Tupper Colleen | Buy | 32.73K | — | — |
| 2026-02-10 | Tupper Colleen | Sell | 11.86K | $46.75 | 554.50K |
| 2026-02-10 | Tupper Colleen | Buy | 26.42K | — | — |
| 2026-02-10 | Tupper Colleen | Sell | 26.68K | $46.75 | 1.25M |
| 2026-02-10 | Dreyer Scott | Buy | 30.70K | — | — |
| 2026-02-10 | Dreyer Scott | Sell | 9.98K | $46.75 | 466.42K |
| 2026-02-10 | Dreyer Scott | Buy | 19.02K | — | — |
| 2026-02-10 | Dreyer Scott | Sell | 21.61K | $46.75 | 1.01M |
| 2025-12-08 | Dreyer Scott | Buy | 17.60K | $15.90 | 279.84K |
| 2025-12-08 | Dreyer Scott | Sell | 11.12K | $47.89 | 532.77K |
| 2025-12-08 | Dreyer Scott | Sell | 6.47K | $48.66 | 315.08K |
| 2025-12-08 | Dreyer Scott | Sell | 17.60K | $15.90 | 279.84K |
| 2025-12-05 | Balice-Gordon Rita J. | Sell | 3.65K | $47.03 | 171.67K |
| 2025-11-12 | Karnani Vikram | Sell | 8.98K | $47.35 | 425.35K |
| 2025-11-12 | Fallon John A. | Buy | 19.85K | $9.33 | 185.23K |
| 2025-11-12 | Fallon John A. | Buy | 15.00K | $16.49 | 247.35K |
| 2025-11-12 | Fallon John A. | Sell | 34.85K | $47.21 | 1.65M |
| 2025-11-12 | Fallon John A. | Sell | 15.00K | $16.49 | 247.35K |
| 2025-11-12 | Fallon John A. | Sell | 19.85K | $9.33 | 185.23K |
| 2025-11-06 | Tupper Colleen | Sell | 25.14K | $40.38 | 1.02M |
| 2025-11-06 | Tupper Colleen | Sell | 4.86K | $41.28 | 200.52K |
| 2025-08-29 | Smith Thomas B | Sell | 17.48K | $38.42 | 671.58K |
| 2025-08-18 | Dreyer Scott | Buy | 16.39K | $21.34 | 349.74K |
| 2025-08-18 | Dreyer Scott | Sell | 16.39K | $38.21 | 626.17K |
| 2025-08-18 | Dreyer Scott | Sell | 16.39K | $21.34 | 349.74K |
| 2025-08-15 | SANTINI GINO | Buy | 15.00K | $13.45 | 201.75K |
| 2025-08-15 | SANTINI GINO | Sell | 5.41K | $37.19 | 201.02K |
| 2025-08-15 | SANTINI GINO | Sell | 15.00K | $13.45 | 201.75K |
| 2025-08-13 | Dreyer Scott | Buy | 4.86K | $21.34 | 103.73K |
| 2025-08-13 | Dreyer Scott | Sell | 4.86K | $38.03 | 184.88K |
| 2025-08-13 | Dreyer Scott | Sell | 4.86K | $21.34 | 103.73K |
| 2025-08-13 | Rubric Capital Management LP | Sell | 25.00K | $37.85 | 946.25K |
| 2025-08-08 | Freund John Gordon | Sell | 11.66K | $34.36 | 400.64K |
| 2025-08-07 | Rubric Capital Management LP | Other | 0 | — | — |
| 2025-06-09 | Freund John Gordon | Buy | 15.00K | $13.45 | 201.75K |
| 2025-06-09 | Freund John Gordon | Sell | 6.60K | $30.62 | 202.15K |
| 2025-06-09 | Freund John Gordon | Sell | 15.00K | $13.45 | 201.75K |
| 2025-05-15 | Fallon John A. | Buy | 9.79K | — | — |
| 2025-05-15 | Lurker Nancy | Buy | 9.79K | — | — |
| 2025-05-15 | BOHLIN GAREN G | Buy | 9.79K | — | — |
| 2025-05-15 | Balice-Gordon Rita J. | Buy | 9.79K | — | — |
| 2025-05-15 | Freund John Gordon | Buy | 9.79K | — | — |
| 2025-05-15 | SANTINI GINO | Buy | 9.79K | — | — |
| 2025-05-15 | Paya Carlos V | Buy | 19.58K | — | — |
| 2025-05-15 | Paya Carlos V | Other | 0 | — | — |
| 2025-03-21 | Tupper Colleen | Sell | 6.40K | $30.03 | 192.07K |
| 2025-03-21 | Dreyer Scott | Sell | 18.88K | $30.03 | 566.98K |
| 2025-03-20 | Tupper Colleen | Sell | 1.21K | $30.00 | 36.18K |
| 2025-03-20 | Dreyer Scott | Sell | 1.93K | $30.00 | 57.81K |
| 2025-03-17 | Dieter David | Buy | 68.45K | — | — |
| 2025-03-17 | Dieter David | Other | 0 | — | — |
| 2025-03-14 | Tupper Colleen | Sell | 977 | $30.00 | 29.31K |
| 2025-03-14 | Dreyer Scott | Sell | 2.25K | $30.00 | 67.66K |
| 2025-03-11 | Dreyer Scott | Sell | 15.39K | $30.00 | 461.67K |
| 2025-03-11 | Tupper Colleen | Sell | 10.45K | $30.01 | 313.41K |
| 2025-03-07 | Tupper Colleen | Sell | 1.50K | $30.00 | 45.12K |
| 2025-03-07 | Dreyer Scott | Sell | 2.35K | $30.00 | 70.45K |
| 2025-03-06 | Dreyer Scott | Sell | 15.39K | $30.00 | 461.67K |
| 2025-03-06 | Tupper Colleen | Sell | 1.95K | $30.00 | 58.47K |
| 2025-03-06 | Dreyer Scott | Sell | 3.29K | $30.00 | 98.85K |
| 2025-03-06 | Kuhlmann Shirley R. | Sell | 26.07K | $28.50 | 742.95K |
| 2025-03-05 | Kuhlmann Shirley R. | Sell | 20.00K | $28.03 | 560.53K |
| 2025-03-04 | Kuhlmann Shirley R. | Buy | 40.00K | $24.03 | 961.20K |
| 2025-03-04 | Kuhlmann Shirley R. | Sell | 40.00K | $28.08 | 1.12M |
| 2025-03-04 | Kuhlmann Shirley R. | Sell | 40.00K | $24.03 | 961.20K |
| 2025-02-10 | Heffernan Michael Thomas | Buy | 4.82K | — | — |
| 2025-02-10 | Smith Thomas B | Buy | 5.31K | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 283, holders +16 vs prior quarter. Ownership 123.52%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 5.44M | 307.18K | +5.98% | 196.97M |
| JUPITER TOPCO LLC | 2.15M | 2.15M | New | 77.74M |
| INVESCO LTD. | 1.88M | 290.59K | +18.25% | 68.15M |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.63M | 133.20K | +8.88% | 59.11M |
| PRINCIPAL FINANCIAL GROUP INC | 1.63M | 337.33K | +26.05% | 59.09M |
| STATE STREET CORP | 1.53M | 104.34K | +7.32% | 55.35M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.41M | 39.63K | +2.90% | 50.88M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.38M | 47.27K | +3.54% | 50.00M |
| RENAISSANCE TECHNOLOGIES LLC | 1.37M | -102.90K | -7.00% | 49.47M |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.36M | -63.05K | -4.43% | 49.27M |
| RUBRIC CAPITAL MANAGEMENT LP | 1.28M | 0 | 0.00% | 46.32M |
| GEODE CAPITAL MANAGEMENT, LLC | 890.89K | 71.45K | +8.72% | 32.26M |
| DIMENSIONAL FUND ADVISORS LP | 837.88K | 4.68K | +0.56% | 30.33M |
| VICTORY CAPITAL MANAGEMENT INC | 760.25K | 134.95K | +21.58% | 27.52M |
| GOLDENTREE ASSET MANAGEMENT LP | 744.89K | 744.89K | New | 26.92M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 740.08K | 59.70K | +8.77% | 26.79M |
| MILLENNIUM MANAGEMENT LLC | 736.92K | 376.10K | +104.23% | 26.68M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 621.92K | -81.61K | -11.60% | 22.51M |
| GOLDMAN SACHS GROUP INC | 556.93K | -18.21K | -3.17% | 20.16M |
| MORGAN STANLEY | 534.76K | 19.58K | +3.80% | 19.36M |
| AMERICAN CENTURY COMPANIES INC | 491.63K | 30.88K | +6.70% | 17.80M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 486.60K | -8.43K | -1.70% | 17.61M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 486.60K | 486.60K | New | 17.61M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 431.45K | -190.49K | -30.63% | 15.62M |
| NORTHERN TRUST CORP | 391.78K | 29.89K | +8.26% | 14.18M |
Collegium Pharmaceutical, Inc. (COLL) trades at $23.17, with a market cap of $754.30M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$754.30M
Market Cap
—
P/E
—
Forward P/E
—
Score